Search Results - Renouf, D.J.

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    A phase II study of erlotinib in gemcitabine refractory advanced pancreatic cancer

    A phase II study of erlotinib in gemcitabine refractory advanced pancreatic cancer by Renouf, D.J, Tang, P.A, Hedley, D, Chen, E, Kamel-Reid, S, Tsao, M.S, Tran-Thanh, D, Gill, S, Dhani, N, Au, H.J, Wang, L, Moore, M.J

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    2404 The association of Mismatch Repair Status and pre-operative albumin levels with survival in resected pancreatic adenocarcinoma

    2404 The association of Mismatch Repair Status and pre-operative albumin levels with survival in resected pancreatic adenocarcinoma by Samimi, S, Kalloger, S, Peixoto, R, Cheung, W.Y, Schaeffer, D, Renouf, D.J

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    508 A phase Ib trial of AMG386 and temsirolimus in patients with advanced sold tumors (PJC-008/NCI#9041)

    508 A phase Ib trial of AMG386 and temsirolimus in patients with advanced sold tumors (PJC-008/NCI#9041) by Chiu, J.W, Hotte, S.J, Kollmannsberger, C.K, Renouf, D.J, Cescon, D.W, Hedley, D, Chow, S, Moscow, J, Perry, M, Diaz-Padilla, I, Tan, D, Hirte, H, McWhirter, E, Chen, H, Siu, L.L, Bedard, P.L

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    97P Population-based assessment of outcomes in pancreatic ductal adenocarcinoma (PDAC) patients (pts) with pathogenic germline variants (PGVs)

    97P Population-based assessment of outcomes in pancreatic ductal adenocarcinoma (PDAC) patients (pts) with pathogenic germline variants (PGVs) by Cheng, P.T.M., Schrader, K., Cremin, C., Cheung, E., Fisic, A., Topham, J., Karasinska, J., Chow, B., Schaeffer, D., Renouf, D.J.

    Published in ESMO open
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    200MO Anti–IL-8 BMS-986253 + nivolumab (NIVO) ± ipilimumab (IPI) in patients (pts) with advanced cancer: Update of initial phase I results

    200MO Anti–IL-8 BMS-986253 + nivolumab (NIVO) ± ipilimumab (IPI) in patients (pts) with advanced cancer: Update of initial phase I results by Simonelli, M., Calvo, E., Davar, D., Richards, D., Gutierrez, M., Moreno Garcia, V., Marron, T., Rottey, S., Orcurto, A., Renouf, D.J., Joerger, M., Barriga Falcon, S., Fan, J., Gibson, E., Chakraborty, D., Arora, V., Melero, I.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Patterns of practice with third-line anti-EGFR antibody for metastatic colorectal cancer

    Patterns of practice with third-line anti-EGFR antibody for metastatic colorectal cancer by Ho, M Y, Renouf, D J, Cheung, W Y, Lim, H J, Speers, C H, Zhou, C, Kennecke, H F

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Personalized oncogenomics in the management of gastrointestinal carcinomas-early experiences from a pilot study

    Personalized oncogenomics in the management of gastrointestinal carcinomas-early experiences from a pilot study by Sheffield, B S, Tessier-Cloutier, B, Li-Chang, H, Shen, Y, Pleasance, E, Kasaian, K, Li, Y, Jones, S J M, Lim, H J, Renouf, D J, Huntsman, D G, Yip, S, Laskin, J, Marra, M, Schaeffer, D F

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Electrochemical Capacitance of Nanocomposite Films Formed by Coating Aligned Arrays of Carbon Nanotubes with Polypyrrole

    Electrochemical Capacitance of Nanocomposite Films Formed by Coating Aligned Arrays of Carbon Nanotubes with Polypyrrole by Hughes, M., Shaffer, M.S.P., Renouf, A.C., Singh, C., Chen, G.Z., Fray, D.J., Windle, A.H.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: